Skip to main content
OliX Pharmaceuticals, Inc. logo

OliX Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · 226950 ISIN · KR7226950004 KO Manufacturing
Open in API
Filings indexed 365 across all filing types
Latest filing 2021-05-14 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 226950

About OliX Pharmaceuticals, Inc.

https://olixpharma.com

OliX Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company specializing in the development of therapeutics based on RNA interference (RNAi) technology. The company leverages its proprietary asymmetric siRNA (asiRNA) platform to create treatments that selectively silence disease-causing genes. Its research and development efforts are focused on building a robust pipeline of drug candidates targeting a variety of illnesses with high unmet medical needs. The pipeline has a particular emphasis on ophthalmic and dermal disorders, with key programs addressing conditions such as hypertrophic scars, age-related macular degeneration (AMD), and other fibrotic and ocular diseases.

Recent filings

Filing Released Lang Actions
분기보고서 (2021.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for OliX Inc. (올릭스(주)) covering the period from January 1, 2021, to March 31, 2021. It contains detailed corporate information, capital structure, shareholding status, and governance details, which are characteristic of a comprehensive interim financial report filed with the Financial Supervisory Service (FSS) in South Korea. It is not an announcement of a report, but the report itself. Q1 2021
2021-05-14 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically functions as a '정정신고' (Correction Report) for a previously submitted stock option grant. It details changes to the number of recipients and the total number of shares granted due to employee departures. This type of filing, which reports on changes to capital-related instruments like stock options, falls under the category of regulatory filings regarding share-based compensation and capital structure adjustments.
2021-05-10 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a 'Correction Report' (정정신고) regarding a previously filed 'Stock Option Grant' (주식매수선택권 부여에 관한 신고). It details changes to the number of shares granted and the list of recipients due to employee departures. In the context of financial filings, reports concerning the issuance or modification of stock options, especially those involving capital structure or equity-based compensation adjustments, are classified under 'Share Issue/Capital Change' (SHA) as they represent changes to the company's potential equity capital.
2021-05-10 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a 'Correction Report' (정정신고) regarding a previously filed 'Stock Option Grant' (주식매수선택권 부여에 관한 신고). It details changes to the number of shares granted and the list of recipients due to employee resignation. In the context of corporate filings, announcements regarding the issuance or modification of stock options, especially those involving capital structure changes or equity-based compensation adjustments, are classified under 'Share Issue/Capital Change' (SHA).
2021-05-10 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and special related parties (specifically a gift of shares between related parties). This type of filing is used to notify the market of significant changes in shareholding percentages, which falls under the category of Major Shareholding Notification.
2021-04-08 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed under the Capital Markets Act in South Korea. It details changes in share ownership by the company's largest shareholder and related parties, including stock option exercises and collateral agreements. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2021-04-05 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.